© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Search results for

Tip: Use operators exact match "", AND, OR to customise your search. You can use them separately or you can combine them to find specific content.
There are 373,197 results that match your search.373,197 results
  • Dar Al Arkan Real Estate Development Company has mandated eight banks to arrange a dollar benchmark five year sukuk.
  • BioPharma Credit, a closed end investment fund that provides debt capital for the life sciences industry, is to raise $300m through a primary placement of new shares to fund further investments.
  • Ma returns to HSBC — Morgan Stanley Indo banker exits — SocGen promotes Malhotra — Credit Suisse loans chief leaves — Citi loses HK, Macau head — JPM dealmaker heads to start-up — UBS sees senior departures
  • Tata Sons is poised to end a decade-long absence from the syndicated loan market when it launches a $1.5bn transaction later this month.
  • India’s Bandhan Bank is set to launch bookbuilding for its Rp44.7bn ($687.5m) IPO next week, according to a notice on Thursday.
  • Finance is a pretty sexy industry, as we all know. Who would ever question the attraction of making money? My mates and I certainly never have — but one friend got a bit more than he bargained for when he innocently called Singapore’s ministry of finance the other day.
  • Chinese video streaming platform Bilibili filed a prospectus with the US market regulator this week, eyeing up to $400m from an IPO of American Depository Shares (ADS).
  • China National Chemical Corp (ChemChina) has raised $6.4bn from a six-tranche transaction in euros and dollars to refinance debt taken for Syngenta’s acquisition. The issuer was willing to pay up to take more on the long end of the curve, with the juicy premium summoning a book of more than $15bn at its peak.
  • The People’s Bank of China’s first update on bank capital regulations in more than a decade has explicitly given the nod to principal write downs, giving banks more options when it comes to switching between the offshore and onshore markets. Addison Gong reports.
  • Regulators in China have finally published issuance guidelines for Belt and Road bonds. But the rules still do not clearly define which bonds qualify, and fail to address issuers’ concerns on capital repatriation and borrowing costs.
  • Temasek Holdings made a splash in the block market this week, raising W1.07tr ($1bn) with a pair of overnight trades in South Korean pharmaceutical company Celltrion and its distribution arm Celltrion Healthcare — an approach that was in line with the Singapore sovereign wealth fund’s strategy to rebalance its portfolio. Jonathan Breen reports.
  • Bank Muscat cut through a weaker market to raise $500m with a new five year senior bond which “all things considered went really well,” and landed flat to where a new Omani sovereign five year would come, according to a banker on the deal.